Tevra Brands LLC v. Bayer HealthCare LLC

Good Law
United States District Court, Northern District of CaliforniaMay 1, 20245:19-cv-04312California7,288 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION 6 TEVRA BRANDS LLC, Case No. 19-cv-04312-BLF

Plaintiff,

ORDER GRANTING IN PART AND

v. DENYING IN PART DEFENDANT'S

MOTION FOR SUMMARY

BAYER HEALTHCARE LLC, et al., JUDGMENT Defendants. [Re: ECF No. 266]

12 Plaintiff Tevra Brands LLC (“Tevra”) brings this antitrust action against Bayer HealthCare LLC (“Bayer”) alleging it engaged in exclusionary practices that substantially restrained trade in the market for topical imidacloprid flea and tick treatments for dogs and cats. Before the Court is Bayer’s Motion for Summary Judgment. ECF No. 266 (“Mot.”); ECF No. 283 (“Reply”). Tevra opposes. ECF No. 278 (“Opp.”). The Court held a hearing on the motion on March 21, 2024. For the reasons stated below, Bayer’s motion is GRANTED IN PART AND DENIED IN PART. I. BACKGROUND Tevra’s Second Amended Complaint (“SAC”) alleges three claims: violations of Sections 1 and…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.